Markers of instability in high-risk carotid plaques are reduced by statins

Hagen Kunte1, Nicola Amberger, Markus Alexander Busch

  • 1Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany. hagen.kunte@charite.de

Journal of Vascular Surgery
|February 26, 2008
PubMed

Insights

Statins appear to stabilize carotid atherosclerotic plaques by reducing macrophage infiltration and matrix metalloproteinase-9 (MMP-9) expression, key indicators of plaque instability. This study confirms these markers and supports statins

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Biomedical Engineering

Background:

  • Macrophage infiltration and matrix metalloproteinase-9 (MMP-9) expression are established markers of high-risk, unstable atherosclerotic carotid plaques.
  • Statins are associated with reduced stroke risk and improved plaque stability, but the underlying mechanisms remain debated.

Purpose of the Study:

  • To investigate the association between statin use and markers of carotid plaque instability, specifically macrophage infiltration and MMP-9 expression.
  • To elucidate the mechanism by which statins may confer plaque stability in patients with carotid artery stenosis.

Main Methods:

  • Retrospective analysis of 94 patients with internal carotid artery stenosis undergoing carotid endarterectomy.
  • Quantitative immunohistochemical analysis of excised plaques to determine macrophage and MMP-9 area percentages.
  • Univariate and multivariate analyses to examine associations between plaque markers, statin use, and cerebrovascular disease.

Main Results:

  • Symptomatic carotid plaques showed significantly higher macrophage and MMP-9 area percentages compared to asymptomatic plaques (P < .0005).
  • Statin-treated patients exhibited significantly lower macrophage and MMP-9 area percentages than untreated patients (P = .01 and P < .0005, respectively).
  • These associations remained significant after controlling for symptomatic disease and other confounders in multivariable analysis.

Conclusions:

  • Macrophage and MMP-9 area percentages are confirmed as reliable indicators of carotid plaque instability.
  • The findings provide robust evidence that statins stabilize atherosclerotic plaques by reducing inflammatory markers, supporting their role in preventing stroke.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...